Source: Veterinary and Comparative Oncology. Unidade: FZEA
Subjects: NEOPLASIAS MAMÁRIAS, ONCOLOGIA VETERINÁRIA, CARCINOGÊNESE ANIMAL, CÃES
ABNT
XAVIER, Pedro Luiz Porfirio et al. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells. Veterinary and Comparative Oncology, v. 16, p. 596-605, 2018Tradução . . Disponível em: https://doi.org/10.1111/vco.12427. Acesso em: 02 nov. 2024.APA
Xavier, P. L. P., Cordeiro, Y. de G., Rochetti, A. L., Sangalli, J. R., Zuccari, D. A. P. de C., Silveira, J. C. da, et al. (2018). ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells. Veterinary and Comparative Oncology, 16, 596-605. doi:10.1111/vco.12427NLM
Xavier PLP, Cordeiro Y de G, Rochetti AL, Sangalli JR, Zuccari DAP de C, Silveira JC da, Bressan FF, Fukumasu H. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells [Internet]. Veterinary and Comparative Oncology. 2018 ; 16 596-605.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/vco.12427Vancouver
Xavier PLP, Cordeiro Y de G, Rochetti AL, Sangalli JR, Zuccari DAP de C, Silveira JC da, Bressan FF, Fukumasu H. ZEB1 and ZEB2 transcription factors are potential therapeutic targets of canine mammary cancer cells [Internet]. Veterinary and Comparative Oncology. 2018 ; 16 596-605.[citado 2024 nov. 02 ] Available from: https://doi.org/10.1111/vco.12427